George Poste

George H.
Poste is Chief Executive Officer at Health Technology Networks, Inc. since 2000.
He is Vice Chairman at Caris Life Sciences, Inc. since 2008.
He serves as Independent Director at Exelixis, Inc. since 2004.
He is Director at Caris Holdings Ltd. and Medisix Therapeutics, Inc. He is a Member of the Council on Foreign Relations, Inc. He is Chief Scientist at Complex Adaptive Systems Initiative since 2009.
He is a Member of The Hoover Institution.
Formerly, Dr. Poste was Non-Executive Chairman at Orchid Cellmark, Inc. from 2000 to 2009, Non-Executive Chairman at diaDexus, Inc. from 1997 to 2004, and Non-Executive Chairman at SGX Pharmaceuticals, Inc. from 2000 to 2004.
He was Director at Caremark Rx, Inc., INanoBio, Inc., Calviri, Inc., AdvancePCS from 2002 to 2005, Illumina, Inc. from 2000 to 2003, Structural Genomix, Inc. from 2000 to 2003, and Monsanto Co. from 2012 to 2018.
He was Director & Professor at Arizona State University from 2003 to 2009 and Director at Biodesign Institute from 2003 to 2009.
He was Chief Science & Technology Officer at GSK Plc and GlaxoSmithKline LLC from 1992 to 1999.
He was Senior Technical Advisor at Caris Ltd. He was Member-Defense Science Board at US Department of Defense from 2001 to 2010.
He was Member of Bipartisan Commission On Biodefense from 2000 to 2009.
Education includes a doctorate from the University of Bristol conferred in 1969 and another doctorate from the University of Bristol conferred in 1987.